Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease

Published:2012-02-12 Issue:2 Volume:14 Page:113-125
ISSN:1092-8480
Container-title:Current Treatment Options in Neurology
language:en
Short-container-title:Curr Treat Options Neurol

Author:

Corbett Anne,Smith Jessica,Creese Byron,Ballard Clive

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical)

Link

http://link.springer.com/content/pdf/10.1007/s11940-012-0166-9.pdf

Reference62 articles.

1. Alzheimer’s Disease International Fact Sheet: The prevalence of dementia worldwide. December 2008. Available at www.alz.co.uk/adi/pdf/prevalence.pdf .

2. Steinberg M, Shao H, Zandi P, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry. 2008;23:170–7.

3. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer’s disease. IV: disorders of behaviour. Br J Psych. 1990;157:86–94.

4. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psych. 2000;157:708–14.

5. Margallo-Lana M, Swann A, O’Brien J, et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatric Psych. 2001;16:39–44.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective Effect of Marrubium vulgare Extract in Scopolamine-Induced Cognitive Impairment in Rats: Behavioral and Biochemical Approaches;Biology;2024-06-09

2. Are psychosocial interventions effective in reducing antipsychotic use for dementia in care home residents? Current evidence and future perspectives;BJPsych Advances;2024-05-15

3. Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis;Journal of Alzheimer's Disease;2024-04-16

4. Validation study of the Persian version of behavioral pathology in Alzheimer’s Disease Rating scale (BEHAVE-AD) and the empirical BHAVE-AD (E-BEHAVE-AD);Applied Neuropsychology: Adult;2023-02-11

5. Anticholinergic effect of resveratrol with vitamin E on scopolamine-induced Alzheimer’s disease in rats: Mechanistic approach to prevent inflammation;Frontiers in Pharmacology;2023-02-02